Literature DB >> 6175806

Effects of mexiletine on steady-state characteristics and recovery kinetics of V max and conduction velocity in guinea pig myocardium.

S Hohnloser, J Weirich, H Antoni.   

Abstract

We studied the effect of the antiarrhythmic compound mexiletine on the maximal rate of rise (V max) on the action potential and on conduction velocity in isolated papillary muscles of guinea pigs. Action potentials and V max were measured by means of conventional microelectrodes. The conduction velocity was determined from extracellular recordings Mexiletine (concentrations, 4.6 x 10(-5) and 1.15 x 10(-4) mol/L) caused a depression of V max that depended on the condition examined. The h infinity curve relating V max of the action potential to the resting membrane potential was shifted along the voltage axis to more negative membrane potentials. Qualitatively equal effects were observed on the curve of membrane responsiveness relating V max to the membrane potential during the phase of repolarization of the preceding action potential. Eventually, marked prolongation of the recovery kinetics of V max by mexiletine, as well as frequency-dependent reduction of V max, could be demonstrated. The action of mexiletine on conduction velocity was very similar to its influence on V max. Thus, prolongation of the recovery kinetics was found of about the same magnitude as that measured in V max. Similarly, in experiments with K + -induced depolarizations, a dependence on the membrane potential of the action of mexiletine on the conduction velocity could be demonstrated. The results suggest that mexiletine may exert antiarrhythmic effects mainly in damaged cardiac cells exhibiting a moderately reduced resting potential.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6175806     DOI: 10.1097/00005344-198203000-00011

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  12 in total

1.  Modelling frequency- and voltage-dependent effects of a class I antiarrhythmic drug (nicainoprol) on Vmax of the cardiac action potential from guinea-pig papillary muscle.

Authors:  J Weirich; H Antoni
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-10       Impact factor: 3.000

2.  Importance of physico-chemical properties in determining the kinetics of the effects of Class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle.

Authors:  T J Campbell
Journal:  Br J Pharmacol       Date:  1983-09       Impact factor: 8.739

3.  Voltage- and time-dependent depression of maximum rate of depolarization of guinea-pig ventricular action potentials by two steroidal antiarrhythmic drugs, CCI 22277 and ORG 6001.

Authors:  T J Campbell
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

4.  Concentration- and rate-dependent electrophysiological effects of restacorin on isolated canine Purkinje fibres.

Authors:  A Varrò; T K Knilans; P P Nànàsi; G Rabloczky; D A Lathrop
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

5.  Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres.

Authors:  E Delpón; C Valenzuela; J Tamargo
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

6.  Effects on transmembrane action potential, slow inward current and force of contraction in ventricular cardiac muscle of BRL 31660, a new antiarrhythmic drug with class I and class IV activity.

Authors:  R Brückner; W Schmitz; H Scholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-03       Impact factor: 3.000

7.  Effects of bepridil on the electrophysiological properties of guinea-pig ventricular muscles.

Authors:  T Anno; T Furuta; M Itho; I Kodama; J Toyama; K Yamada
Journal:  Br J Pharmacol       Date:  1984-04       Impact factor: 8.739

Review 8.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727

9.  Effect of mexiletine, amiodarone and disopyramide on the excitability and refractoriness of canine cardiac fibers: possible relation to antiarrhythmic drug action and classification.

Authors:  Y Nakaya; V Elharrar; B Surawicz
Journal:  Cardiovasc Drugs Ther       Date:  1987-08       Impact factor: 3.727

10.  Electrophysiological mechanism for the antiarrhythmic action of propafenone: a comparison with mexiletine.

Authors:  S Amerini; R Bernabei; P Carbonin; E Cerbai; A Mugelli; M Pahor
Journal:  Br J Pharmacol       Date:  1988-12       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.